Snapshot of the patient-centric trial landscape

Overview of trends in Phase I/II – Phase III industry-sponsored clinical trials In 2009, the FDA issued final guidance on the use of patient-reported outcome measures in clinical trials and how sponsors can use these tools to support labeling claims. Since then, patient-centric trial activity has been fairly stable and consistent.
Read more...

;